XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 29, 2024
Sep. 29, 2023
Current assets:    
Cash and cash equivalents $ 1,205,400 $ 718,800
Marketable securities, current 12,900 15,600
Receivables, net of allowances of $0.9 and $0.8, respectively 615,300 864,300
Inventory 835,500 1,119,700
Other current assets 476,400 461,100
Total current assets 3,145,500 3,179,500
Property, plant, and equipment, net 1,301,400 1,390,100
Operating lease right-of-use assets 204,900 205,400
Goodwill 2,176,700 2,176,700
Intangible assets, net 1,119,500 1,222,100
Deferred tax assets, net 193,900 192,300
Marketable securities, noncurrent 3,000 4,100
Other long-term assets 164,800 56,500
Total assets 8,309,700 8,426,700
Current liabilities:    
Accounts payable 149,800 159,200
Accrued compensation and benefits 106,700 94,300
Current portion of long-term debt 0 299,400
Other current liabilities 349,900 402,800
Total current liabilities 606,400 955,700
Long-term debt 993,600 992,900
Long-term tax liabilities 117,700 162,800
Long-term operating lease liabilities 196,200 188,700
Other long-term liabilities 36,600 43,900
Total liabilities 1,950,500 2,344,000
Stockholders’ equity:    
Preferred stock, no par value: 25.0 shares authorized, no shares issued 0 0
Common stock, $0.25 par value: 525.0 shares authorized; 160.4 shares issued and outstanding at March 29, 2024, and 159.5 shares issued and outstanding at September 29, 2023 40,100 39,900
Additional paid-in capital 252,200 172,400
Retained earnings 6,072,600 5,876,000
Accumulated other comprehensive loss (5,700) (5,600)
Total stockholders’ equity 6,359,200 6,082,700
Total liabilities and stockholders’ equity $ 8,309,700 $ 8,426,700